OS-01 vs GHK-Cu

OS-01 wins for:

• Modulating the PP2A pathway to delay and reverse cellular senescence, especially targeting the root mechanisms of skin aging.
• Clinically-validated impacts on epidermal thickness, fine lines, and systemic inflammation markers without systemic absorption.
• Long-term barrier and skin 'age' improvement confirmed by biomarker shifts.

GHK-Cu wins for:

• Comprehensive, multi-route support of skin repair, collagen synthesis, and hair follicle health with a track record spanning decades.
• Versatility: works for skin, hair, wound healing, and stacks with nearly any actives or compounds in the looksmaxxing protocol.
• Easier sourcing, generic options, and DIY serums enabling customized dosing and targeted regional application.

Pick OS-01 if:

• The protocol calls for mechanistic targeting of skin cell senescence and biological skin aging, not just appearance.
• A systemically neutral, barrier-improving peptide is needed with published clinical results.
• There is willingness to commit to a 12+ week topical protocol with premium, proprietary formulas.
• The whole-body (not just face/hair) skin envelope is being treated as a longevity organ.
• The stack already includes tretinoin or hair-growth topicals and maximal synergy with those is wanted.

Pick GHK-Cu if:

• Rapid gains in surface skin quality, tone, or healing are desired (e.g. visible change in weeks, not months).
• The stack includes hair follicle support (especially with finasteride/minoxidil or RU58841) or acceleration of injury recovery.
• Flexible sourcing, generics, or DIY formulation (1–2% serums, subQ injectables) is important to protocol design or budget.
• The protocol requires compatibility with broad stacks (BPC-157, TB-500, tretinoin, minoxidil, etc.).
• There is a need for targeted, regional application beyond commercial face creams (scalp, joints, surgical sites, etc.).